F057-0301 Screening compound: N-(2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide

F057-0301 Screening compound: N-(2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide
F057-0301 Screening compound: N-(2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F057-0301
N-(2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F057-0301

Molecular Formula

C22H21FN4O3 (C22 H21 FN4 O3)

Compound Name

N-(2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide

IUPAC name

N-(2-{4-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]piperidin-1-yl}-2-oxoethyl)benzamide

SMILES

O=C(CNC(c1ccccc1)=O)N(CC1)CCC1c1nc(-c(cc2)ccc2F)no1

InChI

InChI=1S/C22H21FN4O3/c23-18-8-6-15(7-9-18)20-25-22(30-26-20)17-10-12-27(13-11-17)19(28)14-24-21(29)16-4-2-1-3-5-16/h1-9,17H,10-14H2,(H,24,29)

InChI Key

CAPWFDXZEAXVHB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27096862

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.551

Distribution Coefficient, logD

3.551

Water Solubility, LogSw

-3.53

Polar Surface Area

72.450

Acid Dissociation Constant (pKa)

11.78

Base Dissociation Constant (pKb)

-0.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.30

F057-0301 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with F057-0301 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F057-0301?
Check Price and Availability of F057-0301, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F057-0301 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F057-0301
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F057-0301
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F057-0301 available by request